Radiomics in gliomas: A promising assistance 
for glioma clinical research

Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences
Yueshuang LengYa Cao

Abstract

Gliomas are the most common brain primary tumors worldwide, which is the earliest sequenced cancer gene in the Cancer Genome Atlas (TCGA) project. The World Health Organization Classification Update of Central Nervous System (CNS) Tumors 2016 highlights that glioma is the first tumor classified based on both of the molecular markers and histology. Radiomics is an extraction approach for high-throughput data which collects the quantitative image information appearing. Combined imaging data with genomics and proteomics, radiomics show promising prediction for cancer diagnosis, treatment, and prognosis. In this review, the radiomic analysis methods applied in gliomas are highlighted. Some remarkable findings confirm the considerable potential of radiomics in clinical cancer research.

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Related Papers

The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of Radiopharmaceutica
Philipp LohmannNorbert Galldiks
Nihon rinsho. Japanese journal of clinical medicine
Atsushi NatsumeToshihiko Wakabayashi
Zhonghua zhong liu za zhi [Chinese journal of oncology]
Q Li, Z X Ye
© 2022 Meta ULC. All rights reserved